Various health effects of physical activity (PA) have been well documented in previous studies, 1 and this mounting evidence has laid the foundation for published public health PA recommendations. 2, 3 However most of the evidence to date has relied on self-reported participation in leisure-time PA. Recent progress in body-worn assessment technologies has facilitated direct measurement of PA using objective methods. [4] [5] [6] [7] Among these, simple pedometers represent an economical choice which is appropriate even for individuals interested in personal translation of research findings. As a result, this device is becoming widely accepted not just as an assessment tool but also as an intervention tool. Review articles have reported the efficacy of interventions using pedometers. 8, 9 To use the data obtained from pedometers most effectively, researchers, practitioners, and the lay public require a steps/day index that theoretically reflects underlying relationships with health outcomes, while also remaining consistent with current PA recommendations. For example, Tudor-Locke and Bassett have previously proposed a graduated steps/day index, anchored by 5000 steps/day and increasing in 2500 step increments to 12500 steps/day. 10 Although a few studies have evaluated the validity of this index relative to health outcomes, 11, 12 further research is needed with different populations. Therefore, the objective of this study is to examine the association of step-determined PA categorized according to this index with cardiovascular (CVD) risk factors among middle-aged men and women using the data of the National Health Nutrition Survey of Japan 2006.
Methods The National Health and Nutrition Survey of Japan (NHNS-J)
The data of the NHNS-J 2006 were used for these analyses with the approval of the Ministry of Heath, Labour, and Welfare (MHLW). The NHNS-J has been conducted by MHLW annually since 1945, based on the Health Promotion Act. The purpose of this survey is to collect fundamental health promotion information, mainly from the viewpoint of lifestyle and chronic noncommunicable diseases, among Japanese. The survey includes 3 parts: 1) physical condition, 2) nutritional aspects, and 3) lifestyle. 13 In this study, the results of the physical condition and lifestyle surveys were used for analyses. The survey of physical condition includes anthropometry, blood pressure, blood sampling, interviews on medication status, and pedometer-determined PA. Lifestyle is assessed by questionnaire.
Participants and Data Collection
The administration of the NHNS-J begins with a random selection of 300 census units from all over Japan. 13 All residents in these units aged 1 year or older were invited to participate in the survey. MHLW reported that the eligible sample included about 15000 residents from about 5000 households. Among these 5000 households, 3599 participated in the survey. 13 Participant criteria depended on survey items. For example, blood sampling and interviews on medication status were conducted for individuals ≥ 20 years of age; pedometry and blood pressure measurements were taken for individuals ≥ 15 years of age; and waist circumferences were measured for individuals ≥ 6 years of age. Inclusion criteria for this study were set as 1) 40-to 64-year-old men and women (who were not pregnant or lactating), 2) participants who provided pedometer-determined step data and data for at least 1 CVD risk factor of 5 [body mass index (BMI), waist circumference, blood pressure, high density lipoprotein cholesterol (HDL-C), hemoglobin A1c (HbA1c)]. Participants who reported < 500 steps/day (n = 8) or who reported > 30,000 steps/day (n = 4) were excluded from these analyses as outliers. Among 15,000 eligible residents, 9923 completed at least some parts of the NHNS-J. Among these, 3405 men and women satisfied inclusion criterion "1" and 2619 participants provided data necessary for analyses in this study, thereby meeting inclusion criterion "2." The Ministry of Internal Affairs and Communications of Japan reviewed and approved the survey protocols, and informed consent was obtained from participants.
Physical Condition Survey
The physical condition survey was conducted in November 2006 at a convenient location for participants in each census unit. Physicians, nationally registered dieticians, public health nurses, and clinical laboratory technologists conducted this survey following standardized procedures. Height, body weight, and waist circumference at the navel level were measured. Body mass index (BMI) was calculated by the body weight (kg) divided by the square of height (m). Blood pressure was measured twice (after 5 or more minutes resting) while sitting using a Riva-Rocci sphygmomanometer and an inflatable cuff standardized by Japanese Industrial Standards. The mean values of 2 measurements were used for analyses herein. Blood was taken from the cubital vein. Although the survey protocol encouraged conducting the blood sampling 4 or more hours after a meal, it was not necessarily done consistently under fasting conditions. Thus, the results of triglyceride and plasma glucose tests were not used in this study. HDL-C was measured by direct method using Choletest-N HDL reagent. HbA1c was measured by Latex Aggutination-Turbidimetric Immunoassay. Medication status for hypertension, diabetes, and dyslipidemia was obtained by interview.
Classification of Clustered Risk Factors
Based on anthropometry and biochemical examinations in the NHNS-J, risk factor clustering was assessed. Considering the lack of blood sampling conducted under strict fasting conditions, and that blood glucose and triglyceride could not be included, we followed the analytic methods in the reports of the NHNS-J, which are based on the current diagnostic criteria of the Japanese Society of Internal Medicine for Metabolic syndrome. 14 According to this method, HbA1c levels were used to assess glucose metabolism, and plasma triglyceride levels were not used. Classification of clustered risk factors was based on central obesity as an essential criterion, which is defined as waist circumference of ≥ 85 cm for men and of ≥ 90cm for women. 14 Persons who had central obesity and 2 or more additional risk factors among the following 3 items were defined as clustered risk factors in this study: 1) systolic blood pressure (SBP) of ≥ 130mmHg or diastolic blood pressure (DBP) of ≥ 85mmHg or taking medication for hypertension, 2) HDL-C of < 40mg/dl or taking medication for dyslipidemia, and 3) HbA1c ≥ 5.5% or taking medication for diabetes. The cut point of HbA1c is the proposed value reported by the NHNS-J, which is considered to be equivalent to 110mg/dl of fasting plasma glucose among Japanese. 13 
Pedometer-Determined PA and Other Lifestyle Factors
PA assessment by pedometer was conducted on a single day between Monday and Saturday in November of 2006. The pedometer assessment schedule was set up by each survey office in local health centers. Thus the specific dates of administration differed by participants. The AS-200 (Yamasa Co. Ltd., Tokyo, Japan) was used as the pedometer. Yamasa is the Japanese name for Yamax, a commonly used research-grade pedometer. 15 Survey staff visited each household and asked participants to wear the pedometer on their waists from the time they got up in the morning until the time they went to bed at night, removing the device only to engage in waterbased activities. Participants recorded their steps/day on a survey log and returned it on a subsequently scheduled physical examination day.
Participants completed the self-administered lifestyle questionnaire, which included questions on smoking habits (a nonsmoker was defined someone who had not smoked within the month before the survey), alcohol intake (frequency per week; a drinker was defined as someone who drinks at least once per week), sleeping time (<5, 5-6, 6-7, 7-8, 8-9, ≥9 hours/day) and frequency of snacking (less than 2 times a week, 2-6 times a week, once or more a day, and twice or more a day). Snacking was defined as eating between meals or after supper including drinks with calories such as coffee with milk but not including drinks without calories, such as black coffee. Investigators confirmed the responses when collecting the questionnaires.
Statistical Analyses
Logistic regression analyses were employed to calculate the odds ratios (OR) for having CVD risk factors by steps/ day. As an independent variable, step-determined PA was classified as: sedentary (<5000), low-active (5000-7499), somewhat active (7500-9999), active (10,000-12,499), and high-active (≥12,500), according to the previously proposed graduated step/day index. 10 Dependent variables were BMI, waist circumference, blood pressure, HDL-C, HbA1c, and clustered risk factors. BMI was classified as < 25kg/m 2 (normal weight) or ≥ 25kg/m 2 (overweight/obese). Cut off values of other risk factors were the same as those adopted for the classification of clustered risk factors. Analyses were conducted stratified by sex and adjusted for age, current smoking, drinking (≥ 1 time/week or less), sleeping time (≥ 6 hours/day or less), and snacking (≥ 7 times/week or less). A P-value of less than 0.05 was taken to indicate a statistically significant difference. All statistical analyses were conducted in 2010 with SPSS 17.0J for Windows, SPSS Inc., Tokyo, Japan. Table 1 shows the characteristics of the survey participants. Mean ages of men and women were 53.1 ± 7.0 and 53.0 ± 7.1 years old, respectively. Prevalence of being overweight/obese was 33.2% among men and 23.1% among women; 21.4% of men and 7.9% of women had clustered risk factors. Men took 8041 ± 4458 steps/day and women took 7425 ± 3680 steps/day on average. Comparisons between participants included in the analyses (N = 2619) and participants excluded from the analyses because of a lack of necessary data (N = 786; results are not shown in the table) revealed that this sample was slightly older (mean age of men: 53.1 years vs. 51.6 years, P < .001, women: 53.1 years vs. 51.2 years, P < .001) and had healthier lifestyles (lower smoking rate and less drinkers among women and lower rate of sleeping < 6 hours/day among both genders) compared with excluded participants. However, no significant differences were observed in waist circumference, BMI, step-count, and snacking.
Results
Multiple logistic regression analyses revealed the associations of steps/day with BMI, waist circumference, blood pressure, HbA1c, and clustered risk factors among men (Table 2) . ORs (95% CI; confidence interval) among men taking ≥ 12,500 steps/day compared with those taking < 5000 steps/day were 0.36 (0.23-0.57) for overweight/obese, 0.40 (0.27-0.59) for large waist circumference, 0.49 (0.29-0.84) for high blood pressure, 0.46 (0.25-0.86) for elevated HbA1c, and 0.36 (0.18-0.74) for clustered risk factors. Dose-response relationships were linear between step-defined PA categories and ORs for clustered risk factors among men ( Figure 1A) .
Among women, steps/day were associated only with BMI, waist circumference and blood pressure, and not with HDL-C, HbA1c, and clustered risk factors (Table  2) . ORs (95% CI) among women taking ≥ 12,500 steps/ day compared with those taking < 5000 steps/day were 0.46 (0.27-0.77) for overweight/obese, 0.53 (0.30-0.94) for large waist circumference, and 0.50 (0.32-0.80) for high blood pressure. Even in the low-active category (5000-7499 steps/day), BMI, waist circumference, and blood pressure among women were significantly associated with step-determined PA. Additional decreases in ORs for these risk factors by taking more steps/day were modest among women ( Table 2 ).
Discussion
The results of this study indicated that step-determined PA categorized by the previously proposed graduated steps/day index was associated with some CVD risk factors. Being overweight/obese (defined by BMI), central obesity (defined by waist circumference), and high blood pressure were associated with steps/day among both men and women. Associations of steps/day with HbA1c and clustered risk factors were observed only among men. Gradual decreases in these CVD risk factors across the step-defined PA categories suggest the importance of step-determined PA. The results also suggest the utility of the graduated steps/day index as a basis for encouraging people to increase their activity in small ways. 10 Looking at the shape of the dose-response, the decrease in risk seems linear among men. In contrast, although the decrease in CVD risks such as being overweight and central obesity was relatively large in the low-active group (5000-7499 steps/day) compared with the sedentary group (<5000 steps/day) in women, further decreases in risk associated with taking more steps/day were modest. A previous study reported that individuals achieving 5000 steps/day had a substantially lower prevalence of adverse cardiometabolic health outcomes (eg, metabolic syndrome) than those obtaining fewer steps/day and that the differences in the prevalence of adverse health outcomes were generally modest across higher steps/day categories. 11 A similar shape of the dose-response relationship between obesity and steps/ day was reported in another study. 16 In contrast, our study resulted in a similar conclusion for women, but not for men. Although the benefits of additional PA, in general, are considered to be greater among less active populations, 17 the shape of the dose-response curve differs depending on health outcome. For example, it might be linear for health outcomes related to energy balance, such as obesity and metabolic syndrome. In any case, it was important that even for the lowest active participants, more is better: the second lowest category (5000-7499 steps/day) showed better OR for some risk factors than the sedentary category (<5000 steps/day). In this study, pedometer-determined PA captured as steps/day was associated with CVD risk factors. Total steps/day may include lifestyle activity conducted with light intensity and activities accumulated in bouts shorter than 10 minutes, which were not included in the current PA recommendations. Further studies are needed to examine what proportion of steps/day is accumulated in light intensity and in shorter bouts and how these activities contribute to health, independent of steps taken at higher intensities.
Some unexpected results were obtained from this study. No association of steps/day with HbA1c and clustered risk factors was observed among women. In addition, HDL-C was not associated with steps/day in neither men nor women. We offer some speculations to explain these results. First, this study was conducted by cross-sectional design. Individuals diagnosed with risk factors may be more willing to adopt physically active lifestyles for better health, and especially so among people who are willing to participate in this kind of survey. This could mitigate the association between PA and CVD risk. As to the clustered risk factors among women, sample size was another issue. The proportion of abnormalities observed was only 7.9% in this sample, which was lower compared with those of other risk factors. Thus, the available statistical power might have been insufficient to detect an effect.
There are some limitations in this study. First, as mentioned above, the cross-sectional design does not allow interpretations of the direction of causality. Studies of step-determined PA using longitudinal design are needed in the future. Second, assessment of PA was based on a single day of measurement by pedometer. Previous studies have recommended 3-4 days measurement to assess habitual PA using accelerometry. 18 In contrast, Tudor-Locke et al showed that restricting data to those with 4 or more days of data biases the sample against sedentary individuals. 5 There is insufficient evidence to conclude that a random single day sample is biased. However, if a random single day measurement does cause undifferentiated misclassification of steps/day in the assessment of habitual PA, it could weaken the statistical power in this study. Third, the blood sampling was not necessarily conducted under fasting conditions. As a consequence of this, fasting plasma glucose and triglyceride levels were not analyzed and not included in the classification of clustered risk factors. Fourth, we need to recognize the possibility of selection bias. Participants included in the analyses were slightly older and had healthier profiles of lifestyle than participants excluded from the analyses because of a lack of necessary data. We speculate that, especially among a healthier population, abnormalities of CVD risk factors could motivate people to be active and weaken the associations between steps/day and CVD risk factors in a cross-sectional study.
Despite these limitations, this study demonstrates a gradual reduction of CVD risk associated with higher steps/day categories using Japanese national sample. The findings support the previously proposed graduated steps/ day index and have implications for the understanding of the dose-response relationship between PA and CVD risk.
